Masimo [MASI] vs Penumbra [PEN] Detailed Stock Comparison

Masimo

Penumbra
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Masimo wins in 7 metrics, Penumbra wins in 12 metrics, with 0 ties. Penumbra appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Masimo | Penumbra | Better |
---|---|---|---|
P/E Ratio (TTM) | 129.16 | 67.11 | Penumbra |
Price-to-Book Ratio | 7.45 | 7.58 | Masimo |
Debt-to-Equity Ratio | 61.58 | 17.04 | Penumbra |
PEG Ratio | 0.60 | -0.39 | Penumbra |
EV/EBITDA | 53.69 | 54.34 | Masimo |
Profit Margin (TTM) | -21.32% | 11.54% | Penumbra |
Operating Margin (TTM) | 17.12% | 12.03% | Masimo |
EBITDA Margin (TTM) | 17.12% | 12.03% | Masimo |
Return on Equity | -22.37% | 12.03% | Penumbra |
Return on Assets (TTM) | 1.84% | 6.20% | Penumbra |
Free Cash Flow (TTM) | $145.30M | $147.30M | Penumbra |
1-Year Return | 5.20% | 30.18% | Penumbra |
Price-to-Sales Ratio (TTM) | 3.61 | 7.72 | Masimo |
Enterprise Value | $8.26B | $9.61B | Penumbra |
EV/Revenue Ratio | 3.83 | 7.51 | Masimo |
Gross Profit Margin (TTM) | 62.90% | 65.99% | Penumbra |
Revenue per Share (TTM) | $40 | $33 | Masimo |
Earnings per Share (Diluted) | $-5.15 | $3.75 | Penumbra |
Beta (Stock Volatility) | 1.23 | 0.45 | Penumbra |
Masimo vs Penumbra Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Masimo | 2.46% | 4.51% | 6.03% | -14.76% | -14.83% | -13.36% |
Penumbra | 1.55% | 1.72% | -5.94% | 1.50% | -8.60% | 5.63% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Masimo | 5.20% | 8.76% | -39.76% | 269.00% | 412.82% | 629.52% |
Penumbra | 30.18% | 39.85% | 17.32% | 541.75% | 513.78% | 513.78% |
News Based Sentiment: Masimo vs Penumbra
Masimo
News based Sentiment: POSITIVE
Masimo made significant strategic moves in September, including the divestiture of Sound United and an expanded partnership with Philips. These actions, coupled with positive clinical data and analyst upgrades, suggest a positive trajectory for the company, despite some mixed signals from insider activity and a recent legal settlement. The focus on core healthcare technologies positions Masimo for future growth.
Penumbra
News based Sentiment: MIXED
September presented a mixed bag for Penumbra, with strong financial results and positive analyst coverage offset by insider selling and a downgrade. The company's growth prospects remain promising, but the conflicting signals suggest a degree of uncertainty that warrants careful consideration by investors.
Performance & Financial Health Analysis: Masimo vs Penumbra
Metric | MASI | PEN |
---|---|---|
Market Information | ||
Market Cap | $7.77B | $9.95B |
Market Cap Category | Mid cap | Mid cap |
10 Day Avg. Volume | 737,950 | 440,090 |
90 Day Avg. Volume | 655,770 | 462,633 |
Last Close | $146.05 | $253.49 |
52 Week Range | $131.60 - $194.88 | $187.84 - $310.00 |
% from 52W High | -25.06% | -18.23% |
All-Time High | $305.21 (Nov 15, 2021) | $348.67 (Jun 26, 2023) |
% from All-Time High | -52.15% | -27.30% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.08% | 0.13% |
Quarterly Earnings Growth | 2.21% | 0.13% |
Financial Health | ||
Profit Margin (TTM) | -0.21% | 0.12% |
Operating Margin (TTM) | 0.17% | 0.12% |
Return on Equity (TTM) | -0.22% | 0.12% |
Debt to Equity (MRQ) | 61.58 | 17.04 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $19.20 | $33.20 |
Cash per Share (MRQ) | $2.75 | $10.89 |
Operating Cash Flow (TTM) | $176.60M | $201.49M |
Levered Free Cash Flow (TTM) | $92.86M | $97.77M |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | $0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Masimo vs Penumbra
Metric | MASI | PEN |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 129.16 | 67.11 |
Forward P/E | 30.81 | 66.57 |
PEG Ratio | 0.60 | -0.39 |
Price to Sales (TTM) | 3.61 | 7.72 |
Price to Book (MRQ) | 7.45 | 7.58 |
Market Capitalization | ||
Market Capitalization | $7.77B | $9.95B |
Enterprise Value | $8.26B | $9.61B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 3.83 | 7.51 |
Enterprise to EBITDA | 53.69 | 54.34 |
Risk & Other Metrics | ||
Beta | 1.23 | 0.45 |
Book Value per Share (MRQ) | $19.20 | $33.20 |
Financial Statements Comparison: Masimo vs Penumbra
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | MASI | PEN |
---|---|---|
Revenue/Sales | $372.00M | $324.14M |
Cost of Goods Sold | $138.00M | $108.26M |
Gross Profit | $234.00M | $215.88M |
Research & Development | $33.90M | $22.08M |
Operating Income (EBIT) | $80.70M | $40.35M |
EBITDA | $90.70M | $49.20M |
Pre-Tax Income | $68.40M | $43.86M |
Income Tax | $21.20M | $4.64M |
Net Income (Profit) | $-170.70M | $39.22M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | MASI | PEN |
---|---|---|
Cash & Equivalents | $130.80M | $376.05M |
Total Current Assets | $1.18B | $999.71M |
Total Current Liabilities | $546.50M | $158.63M |
Long-Term Debt | $657.70M | $205.85M |
Total Shareholders Equity | $946.40M | $1.21B |
Retained Earnings | $1.32B | $99.23M |
Property, Plant & Equipment | $183.60M | $274.92M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | MASI | PEN |
---|---|---|
Operating Cash Flow | $62.60M | $46.01M |
Capital Expenditures | $17.00M | $-13.47M |
Free Cash Flow | $27.00M | $35.50M |
Debt Repayment | $-78.80M | $-613,000 |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | MASI | PEN |
---|---|---|
Shares Short | 3.72M | 1.98M |
Short Ratio | 6.13 | 4.25 |
Short % of Float | 0.10% | 0.07% |
Average Daily Volume (10 Day) | 737,950 | 440,090 |
Average Daily Volume (90 Day) | 655,770 | 462,633 |
Shares Outstanding | 53.60M | 38.49M |
Float Shares | 46.46M | 37.78M |
% Held by Insiders | 0.06% | 0.04% |
% Held by Institutions | 1.10% | 0.93% |
Dividend Analysis & Yield Comparison: Masimo vs Penumbra
Metric | MASI | PEN |
---|---|---|
Last 12-Month Dividend | $0.00 | N/A |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | $0.00 | N/A |
3-Year Avg Dividend Yield | N/A | N/A |
3-Year Total Dividends | $0.00 | N/A |
Ex-Dividend Date | N/A | N/A |